Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan;37(1):95-101.
doi: 10.1177/19458924221120117. Epub 2022 Aug 11.

Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician

Affiliations

Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician

Joseph B Gary et al. Am J Rhinol Allergy. 2023 Jan.

Abstract

Background: Nearly 40% of patients who experience smell loss during SARS-CoV-2 infection may develop qualitative olfactory dysfunction, most commonly parosmia. Our evidence-based review summarizes the evolving literature and offers recommendations for the clinician on the management of patients experiencing parosmia associated with COVID-19.

Methods: We performed a systematic search using independent queries in PubMed, Embase, Ovid, and Cochrane databases, then categorized articles according to themes that emerged regarding epidemiology, effect on quality of life, disease progression, prognosis, pathophysiology, diagnosis, and treatment of parosmia.

Results: We identified 123 unique references meeting eligibility and performed title and abstract review with 2 independent reviewers, with 74 articles undergoing full-text review. An inductive approach to thematic development provided 7 central themes regarding qualitative olfactory dysfunction following COVID-19.

Conclusions: While other respiratory viruses are known to cause qualitative olfactory disturbances, the incidence of parosmia following COVID-19 is notable, and correlates negatively with age. The presence of parosmia predicts persistent quantitative olfactory dysfunction. Onset can occur months after infection, and symptoms may persist for well over 7 months. Affected patients report increased anxiety and decreased quality of life. Structured olfactory training with essential oils is the preferred treatment, where parosmia predicts recovery of aspects of quantitative smell loss when undergoing training. There is limited evidence that nasal corticosteroids may accelerate recovery of olfactory function. Patients should be prepared for the possibility that symptoms may persist for years, and providers should guide them to resources for coping with their psychosocial burden.

Keywords: COVID-19; SARS-CoV-2; anosmia; hyposmia; long COVID; olfactory training; parosmia; phantosmia; post viral olfactory dysfunction; qualitative olfactory dysfunction.

PubMed Disclaimer

Conflict of interest statement

The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

References

    1. Rocke J, Hopkins C, Philpott C, Kumar N. Is loss of sense of smell a diagnostic marker in COVID-19: a systematic review and meta-analysis. Clin Otolaryngol. 2020;45(6):914–922. - PMC - PubMed
    1. Lechien JR, Chiesa-Estomba CM, De Siati DR, et al.Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Oto-Rhino-Laryngol. 2020;277(8):2251–2261. - PMC - PubMed
    1. Menni C, Valdes AM, Freidin MB, et al.Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020;26(7):1037–1040. - PMC - PubMed
    1. Boscolo-Rizzo P, Menegaldo A, Fabbris Cet al.Six-month psychophysical evaluation of olfactory dysfunction in patients with COVID-19. Chem Senses. Published online2021;46. doi:10.1093/chemse/bjab006 - DOI - PMC - PubMed
    1. Boscolo-Rizzo P, Guida F, Polesel J, et al.. Self-reported smell and taste recovery in COVID-19 patients: a one-year prospective study. medRxiv. Published online2021. doi:10.1101/2021.03.18.21253862 - DOI - PMC - PubMed

Publication types